Previous Close | 26.62 |
Open | 26.23 |
Bid | 25.76 x 100 |
Ask | 26.12 x 200 |
Day's Range | 25.78 - 26.60 |
52 Week Range | 22.82 - 53.38 |
Volume | |
Avg. Volume | 78,893 |
Market Cap | 187.167M |
Beta (5Y Monthly) | 0.89 |
PE Ratio (TTM) | 10.12 |
EPS (TTM) | 2.56 |
Earnings Date | May 07, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Semler Scientific, Inc. (Nasdaq: SMLR), a company that develops, manufactures and markets innovative medical products and services that assist in evaluating and treating chronic diseases, today announced that it will report financial results for the first quarter ended March 31, 2024, after the close of U.S. financial markets on Tuesday, May 7, 2024. Doug Murphy-Chutorian, M.D., chief executive officer of Semler Scientific, will host a conference call at 4:30 pm ET the same day. Renae Cormier, c
Every investor on earth makes bad calls sometimes. But you want to avoid the really big losses like the plague. So take...
With its stock down 37% over the past month, it is easy to disregard Semler Scientific (NASDAQ:SMLR). However, stock...